公司資料
Nanobiotix 股價、新聞與催化劑
- 股票代碼:
- NBTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- France and listed in the U
股票表現
43.68 USD (-3.77%)
收盤價
最後更新: 2026年8月20日
1.86B USD
市值
股價為何變動
As of Aug 20, 2026, NBTX closed down 3.77% at $43.68. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Nanobiotix is a radiotherapy and oncology company focused on nanoparticle-enabled cancer treatment. Its platform is built around improving how radiation interacts with tumors.
所在地與產業分類
Headquartered in France and listed in the U.S. as an ADR, Nanobiotix has a global oncology-biotech profile.
商業模式特徵
The business depends on clinical data, regulatory progress, and the ability to translate nanoparticle science into cancer value.
生技產業定位
Nanobiotix is a catalyst-driven oncology name whose stock reacts strongly to development and partnership updates.
未來催化劑
- Nanobiotix’s catalysts are its radioenhancer platform and any oncology update that shows the technology can improve local control without unacceptable toxicity. The market will care about whether the platform continues to look clinically relevant.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。